We demonstrated that treatment with CNP-miR146a following MRSA infection significantly reduced expression and production of IL-6, IL-8, IL-1β, and TNFα, which may function to prevent amplification of the positive feedback inflammatory cascade that is hallmark of ARDS. Here, IL6 is linked to acute respiratory distress syndrome.